[Experience with the use of vilozen in patients with bronchial asthma].

Abstract	The results of the use of vilozen in the treatment of bronchial asthma patients are presented. The efficacy of the drug for asthma of different genesis is demonstrated. Vilozen stimulates functions of cellular immunity and produces a moderate inhibitory effect on phagocytosis function. The drug is contraindicated in the treatment of patients with bacterial infection and pronounced obstructive syndrome.
Authors	S I Ialkut, S A Kotova
Journal	Terapevticheskii arkhiv (Ter Arkh) Vol. 61 Issue 8 Pg. 55-7 ( 1989) ISSN: 0040-3660 [Print] Russia (Federation)
Vernacular Title	Opyt primeneniia vilozena u bol'nykh bronkhial'noĭ astmoĭ.
PMID	2588167 (Publication Type: Comparative Study, English Abstract, Journal Article)
Chemical References	Adjuvants, Immunologic Solutions Thymus Extracts iilozen
Topics	Adjuvants, Immunologic (administration & dosage, therapeutic use) Administration, Intranasal Antibody Formation (drug effects, immunology) Asthma (drug therapy, immunology) Drug Evaluation Humans Immunity, Cellular (drug effects, immunology) Solutions Thymus Extracts (administration & dosage, therapeutic use) Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!